Klobuchar Statement on Newly Released Prices for 15 Additional Prescription Drugs Subject to Medicare Negotiations
November 25, 2025
November 25, 2025
WASHINGTON, Nov. 25 -- Sen. Amy Klobuchar, D-Minnesota, issued the following news release:
* * *
Klobuchar Statement on Newly Released Prices for 15 Additional Prescription Drugs Subject to Medicare Negotiations
*
WASHINGTON U.S. Senator Amy Klobuchar (D-MN), who led the Empowering Medicare Seniors to Negotiate Drug Prices Act to end the nearly 20-year ban on Medicare negotiating lower prescription drug prices for consumers, released the follow . . .
* * *
Klobuchar Statement on Newly Released Prices for 15 Additional Prescription Drugs Subject to Medicare Negotiations
*
WASHINGTON U.S. Senator Amy Klobuchar (D-MN), who led the Empowering Medicare Seniors to Negotiate Drug Prices Act to end the nearly 20-year ban on Medicare negotiating lower prescription drug prices for consumers, released the follow . . .
